Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib

Bridget N. Fahy, Michael G. Schlieman, Melinda M. Mortenson, Subbulakshmi Virudachalam, Richard J Bold

Research output: Contribution to journalArticle

112 Scopus citations

Fingerprint Dive into the research topics of 'Targeting BCL-2 overexpression in various human malignancies through NF-κB inhibition by the proteasome inhibitor bortezomib'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences